Toleranzia (Sweden) Today
| TOL Stock | SEK 0.59 0.02 3.51% |
Performance4 of 100
| Odds Of DistressLess than 18
|
Toleranzia is selling for under 0.59 as of the 15th of December 2024; that is 3.51 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.59. Toleranzia has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 15th of November 2024 and ending today, the 15th of December 2024. Click here to learn more.
Moving against Toleranzia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Toleranzia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Toleranzia's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Toleranzia or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Toleranzia AB (TOL) is traded on Stockholm Exchange in Sweden and employs 9 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 131.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Toleranzia's market, we take the total number of its shares issued and multiply it by Toleranzia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Toleranzia AB operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 110.31 M outstanding shares.
Toleranzia generates negative cash flow from operations
Check Toleranzia Probability Of Bankruptcy
Ownership AllocationToleranzia AB shows a total of 110.31 Million outstanding shares. Toleranzia AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Toleranzia Ownership Details
Toleranzia AB Risk Profiles
Although Toleranzia's alpha and beta are two of the key measurements used to evaluate Toleranzia's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.22 | |||
| Semi Deviation | 3.56 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.38 |
Toleranzia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Toleranzia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Toleranzia Corporate Management
Elected by the shareholders, the Toleranzia's board of directors comprises two types of representatives: Toleranzia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Toleranzia. The board's role is to monitor Toleranzia's management team and ensure that shareholders' interests are well served. Toleranzia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Toleranzia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charlotte Fribert | Chief Officer | Profile | |
| Vidar MD | Chief Officer | Profile | |
| Torbjrn Sannerstedt | Chief Officer | Profile | |
| Bjrn Lwenadler | Chief Officer | Profile |
Additional Tools for Toleranzia Stock Analysis
When running Toleranzia's price analysis, check to measure Toleranzia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Toleranzia is operating at the current time. Most of Toleranzia's value examination focuses on studying past and present price action to predict the probability of Toleranzia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Toleranzia's price. Additionally, you may evaluate how the addition of Toleranzia to your portfolios can decrease your overall portfolio volatility.